TRx0014

DRUG2 trials

Sponsors

TauRx Therapeutics Ltd

Conditions

Alzheimer's DiseaseDementia, Alzheimer Type

Phase 2

TRx0014 in Patients With Mild or Moderate Alzheimer's Disease

CompletedNCT00515333

TauRx Therapeutics LtdDementia, Alzheimer Type

Start: 2004-08-31End: 2007-12-31Updated: 2008-02-20

Open Label Study of TRx0014 in Alzheimer's Disease

CompletedNCT00684944

TauRx Therapeutics LtdAlzheimer's Disease

Start: 2007-09-13End: 2010-12-02Updated: 2018-04-27

Related Papers

Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease.

2015-01-01188 citations